• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼莫地平联合拉坦前列素治疗开角型青光眼的疗效及其对眼血流动力学和视野缺损的影响。

Efficacy of Nimodipine Combined with Latanoprost in Treating Open-Angle Glaucoma and Its Influence on Ocular Hemodynamics and Visual Field Defects.

机构信息

Department of Ophthalmology, Shanxi Province Fenyang Hospital, Fenyang, 032200, Shanxi Province, People's Republic of China.

Department of Ophthalmology, Shanxi Datong University, Datong, 037000, Shanxi Province, People's Republic of China.

出版信息

Drug Des Devel Ther. 2022 Mar 21;16:749-757. doi: 10.2147/DDDT.S352876. eCollection 2022.

DOI:10.2147/DDDT.S352876
PMID:35340339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8956248/
Abstract

BACKGROUND

Open-angle glaucoma is a common ophthalmic disease, which has a great impact on the vision of middle-aged and elderly people. Medication plays an important role in the treatment of glaucoma, so finding effective drug treatment is of great significance to improve the quality of life of glaucoma patients.

OBJECTIVE

To explore the curative effect of nimodipine combined with latanoprost in the treatment of open-angle glaucoma and its effect on ocular hemodynamics and visual field defects.

METHODS

This study retrospectively analyzed the clinical data of 87 patients with open-angle glaucoma who came to the Shanxi Province Fenyang Hospital and The First Affiliated Hospital of Shanxi Datong University for treatment from January 2019 to January 2021. According to different treatment plans, the patients were divided into two groups: an observation group (n = 46) treated with nimodipine combined with latanoprost, and a control group (n = 41) treated by latanoprost monotherapy. Treatment efficacy, hemodynamics, visual field defects, 24-hour peak intraocular pressure, binocular optic disc parameters, adverse reactions and quality of life were recorded and compared between two groups of patients.

RESULTS

The overall therapeutic effect of the observation group was significantly better than that in the control group. After treatment, ocular hemodynamics, visual field defects, 24-hour peak intraocular pressure, binocular optic disc parameters and life quality of both groups were obviously improved compared to those before treatment, with more significant improvements in the observation group. In addition, there was no significant difference in the incidence of adverse reactions between the two groups.

CONCLUSION

Nimodipine combined with latanoprost eye drops is effective in the treatment of primary open-angle glaucoma, which could effectively improve the ocular hemodynamics and visual field defects of patients with fewer adverse reactions and higher safety. Therefore, it can be further promoted and used in clinical practice.

摘要

背景

开角型青光眼是一种常见的眼科疾病,对中老年人的视力影响较大。药物治疗在青光眼的治疗中起着重要作用,因此寻找有效的药物治疗方法对于提高青光眼患者的生活质量具有重要意义。

目的

探讨尼莫地平联合拉坦前列素治疗开角型青光眼的疗效及其对眼血流动力学和视野缺损的影响。

方法

本研究回顾性分析了 2019 年 1 月至 2021 年 1 月山西省汾阳医院和山西大同大学第一附属医院收治的 87 例开角型青光眼患者的临床资料。根据不同的治疗方案将患者分为观察组(n=46)和对照组(n=41),观察组给予尼莫地平联合拉坦前列素治疗,对照组给予拉坦前列素单药治疗。记录并比较两组患者的治疗效果、血流动力学、视野缺损、24 小时眼压峰值、双眼视盘参数、不良反应及生活质量。

结果

观察组总有效率明显优于对照组。治疗后两组患者的眼血流动力学、视野缺损、24 小时眼压峰值、双眼视盘参数及生活质量均明显优于治疗前,观察组改善更明显。此外,两组不良反应发生率无显著差异。

结论

尼莫地平联合拉坦前列素滴眼液治疗原发性开角型青光眼疗效显著,能有效改善患者的眼血流动力学和视野缺损,不良反应少,安全性高,可在临床进一步推广应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1031/8956248/c73e23ff2f2b/DDDT-16-749-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1031/8956248/a0060a5d2710/DDDT-16-749-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1031/8956248/ad66d54a516a/DDDT-16-749-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1031/8956248/c73e23ff2f2b/DDDT-16-749-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1031/8956248/a0060a5d2710/DDDT-16-749-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1031/8956248/ad66d54a516a/DDDT-16-749-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1031/8956248/c73e23ff2f2b/DDDT-16-749-g0003.jpg

相似文献

1
Efficacy of Nimodipine Combined with Latanoprost in Treating Open-Angle Glaucoma and Its Influence on Ocular Hemodynamics and Visual Field Defects.尼莫地平联合拉坦前列素治疗开角型青光眼的疗效及其对眼血流动力学和视野缺损的影响。
Drug Des Devel Ther. 2022 Mar 21;16:749-757. doi: 10.2147/DDDT.S352876. eCollection 2022.
2
[Randomized parallel group study of 0.0015% tafluprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension (comparison with 0.005% latanoprost ophthalmic solution)].0.0015%他氟前列素滴眼液治疗原发性开角型青光眼或高眼压症患者的随机平行组研究(与0.005%拉坦前列素滴眼液对比)
Zhonghua Yan Ke Za Zhi. 2015 Feb;51(2):95-102.
3
Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups.拉坦前列素,一种前列腺素类似物,用于青光眼治疗。198例患者治疗1年后的疗效和安全性。拉坦前列素研究组
Ophthalmology. 1996 Nov;103(11):1916-24. doi: 10.1016/s0161-6420(96)30407-7.
4
A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial.溴莫尼定与拉坦前列素治疗成人开角型青光眼或高眼压症的疗效及耐受性比较:一项为期三个月的多中心、随机、双盲、平行组试验。
Clin Ther. 2001 Dec;23(12):1969-83. doi: 10.1016/s0149-2918(01)80150-8.
5
[Unpreserved latanoprost in the treatment of open-angle glaucoma and ocular hypertension. A multicenter, randomized, controlled study].[未保存的拉坦前列素治疗开角型青光眼和高眼压症。一项多中心、随机、对照研究]
J Fr Ophtalmol. 2016 Sep;39(7):622-30. doi: 10.1016/j.jfo.2016.05.006. Epub 2016 Aug 25.
6
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.曲伏前列素与拉坦前列素和噻吗洛尔在开角型青光眼或高眼压症患者中的比较。
Am J Ophthalmol. 2001 Oct;132(4):472-84. doi: 10.1016/s0002-9394(01)01177-1.
7
Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension.开角型青光眼或高眼压症患者使用不含防腐剂与含防腐剂的拉坦前列素滴眼液的对比研究
Curr Med Res Opin. 2016 Aug;32(8):1457-63. doi: 10.1080/03007995.2016.1202818. Epub 2016 Jun 25.
8
Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension.多中心、随机、对照研究比较曲伏前列素/噻吗洛尔固定复方与拉坦前列素/噻吗洛尔固定复方治疗原发性开角型青光眼和高眼压症。
Adv Ther. 2018 Jun;35(6):796-808. doi: 10.1007/s12325-018-0718-9. Epub 2018 Jun 5.
9
A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension.一项随机双盲交叉研究,比较0.005%拉坦前列素与0.12%乌诺前列酮在原发性开角型青光眼和高眼压症患者中的疗效。
Am J Ophthalmol. 2001 May;131(5):636-42. doi: 10.1016/s0002-9394(00)00943-0.
10
Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.多佐胺-噻吗洛尔单独使用或与拉坦前列素联合使用治疗开角型青光眼或高眼压症的有效性和安全性。
Ann Pharmacother. 2008 Apr;42(4):498-504. doi: 10.1345/aph.1K565. Epub 2008 Mar 25.

引用本文的文献

1
Analysis of the relationship between VEGF, NLRP3 inflammatory complex, EPO levels, and ocular hemodynamics in patients with primary open-angle glaucoma.分析原发性开角型青光眼患者血管内皮生长因子(VEGF)、NLRP3 炎症复合物、EPO 水平与眼血流动力学的关系。
BMC Ophthalmol. 2024 Aug 8;24(1):331. doi: 10.1186/s12886-024-03600-9.
2
Neuroprotection in Glaucoma: Basic Aspects and Clinical Relevance.青光眼的神经保护:基础方面与临床相关性
J Pers Med. 2022 Nov 10;12(11):1884. doi: 10.3390/jpm12111884.

本文引用的文献

1
Risk factors for open-angle glaucoma and recommendations for glaucoma screening.开角型青光眼的危险因素和青光眼筛查建议。
Ophthalmologe. 2021 Jul;118(Suppl 2):145-152. doi: 10.1007/s00347-021-01378-5. Epub 2021 Apr 21.
2
Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma.比较拉坦前列素噁唑啉、马来酸噻吗洛尔和拉坦前列素滴眼液,评估它们在降低开角型青光眼眼压管理中的安全性和有效性。
Clinics (Sao Paulo). 2020 Nov 30;75:e1874. doi: 10.6061/clinics/2020/e1874. eCollection 2020.
3
[Genome-wide studies of primary open-angle glaucoma].
[原发性开角型青光眼的全基因组研究]
Vestn Oftalmol. 2020;136(5):129-135. doi: 10.17116/oftalma2020136051129.
4
Baseline structural characteristics of the optic nerve head and retinal nerve fiber layer are associated with progressive visual field loss in patients with open-angle glaucoma.视盘和视网膜神经纤维层的基线结构特征与开角型青光眼患者进行性视野丧失有关。
PLoS One. 2020 Aug 20;15(8):e0236819. doi: 10.1371/journal.pone.0236819. eCollection 2020.
5
Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2.固定剂量组合奈他舒地尔和拉坦前列素治疗眼高压和开角型青光眼:3 期 MERCURY-1 和 -2 的汇总疗效/安全性分析。
Adv Ther. 2020 Apr;37(4):1620-1631. doi: 10.1007/s12325-020-01277-2. Epub 2020 Mar 12.
6
Vitreous albumin redox state in open-angle glaucoma patients and controls: a pilot study.开角型青光眼患者和对照者玻璃体白蛋白氧化还原状态的初步研究。
Int Ophthalmol. 2020 Apr;40(4):999-1006. doi: 10.1007/s10792-019-01268-5. Epub 2020 Jan 11.
7
Netarsudil and latanoprost ophthalmic solution for the reduction of intraocular pressure in open-angle glaucoma or ocular hypertension.尼达尼布滴眼液和拉坦前列素滴眼液降低开角型青光眼或高眼压症患者的眼内压。
Expert Rev Clin Pharmacol. 2019 Dec;12(12):1073-1079. doi: 10.1080/17512433.2019.1701435.
8
Relationship between primary open angle glaucoma and blood pressure.原发性开角型青光眼与血压之间的关系。
Acta Cardiol. 2020 Feb;75(1):54-58. doi: 10.1080/00015385.2018.1549004. Epub 2019 Jan 16.
9
[Primary open-angle glaucoma].[原发性开角型青光眼]
Rev Med Interne. 2019 Jul;40(7):445-452. doi: 10.1016/j.revmed.2018.12.001. Epub 2018 Dec 26.
10
Concordance of 24-h intraocular pressure curve in patients with untreated unilateral primary open-angle glaucoma.未经治疗的单侧原发性开角型青光眼患者24小时眼压曲线的一致性
Exp Ther Med. 2018 Aug;16(2):1461-1469. doi: 10.3892/etm.2018.6315. Epub 2018 Jun 15.